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UK; 4EuroQol Executive Ofﬁce, Rotterdam, The NetherlandsA B S T R A C TBackground: Studies to produce value sets for preference-based
measures of health require deﬁnition of a full health upper anchor
if the values are to be used to calculate quality-adjusted life years.
Recent value sets derived for the EQ-5D-5L instrument have described
the upper anchor as “full health,” whereas older valuation studies for
the EQ-5D used “best health state” in the descriptive system (11111). It
is unclear whether this change could have led to differences in the
values obtained. The objective of this study was to assess differences
in time trade-off (TTO) valuations using two different comparators
(full health and 11111). Methods: Preferences for EQ-5D-5L health
states were elicited from a broadly representative sample of the UK
general public. TTO data were collected by using computer-assisted
personal interviews. Respondents were randomly allocated to one of
two arms, each using a different comparator health state. Respondentsee front matter & 2016 Published by Elsevier Inc.
(ISPOR).
.1016/j.jval.2015.10.012
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ndence to: Koonal Kirit Shah, Ofﬁce of Health Econcompleted 10 or 11 TTO valuations and a series of follow-up questions
examining their interpretations of the term “full health.” Results:
Interviews with 443 respondents were completed in 2014. The differ-
ences in mean values across arms are mostly small and nonsigniﬁ-
cant. The two arms produced data of similar quality. There is evidence
of interviewer effects. Health state 11111 was given a value of 1 by
98.2% of the respondents who valued it. Conclusions: EQ-5D-5L
values elicited by using the composite TTO approach are not greatly
affected by the use of full health or 11111 as the comparator
health state.
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Pharmacoeconomics and Outcomes Research (ISPOR).Introduction
Preference-based measures of health are commonly used to
assess the impacts of health interventions and to inform calcu-
lations of quality-adjusted life years (QALYs) in economic evalu-
ations. To use the data from these measures in the estimation of
QALYs, the instruments must be accompanied by “value sets,”
which provide, for each health state described by the descriptive
system, a value summarizing how good or bad that health state is
considered to be by a representative sample of the general
population. The values lie on a scale anchored at 1 (“full health”)
and 0 (dead), with values of less than 0 assigned to health states
considered “worse than dead.”
Several choice-based methods are available to elicit health state
values, including time trade-off (TTO) and standard gamble. In TTO
tasks, survey respondents face a series of choices between two
hypothetical “lives”: one involving a period of time in an impaired
health state and the other involving a shorter period of time in a
comparator health state with no health problems. The valuation ofthe impaired health state is calculated according to how much time
in the comparator state the respondent is willing to give up at the
point at which the person is indifferent between the two lives. Within
the choice task, the comparator state could be deﬁned either as being
in the best level of each dimension on the measure being valued, or
in generic terms such as “healthy,” “full health,” or “perfect health.”
Different generic preference-based measures have taken alter-
native approaches to this issue. In the standard gamble exercises
used to value the Health Utilities Index 3 [1] and SF-6D [2] instru-
ments, health states were valued in relation to the best states
deﬁned by the respective descriptive systems of the measures. In
the TTO exercise used to value the Assessment of Quality of Life II
instrument, the comparator state was “excellent health,” although
additional wording was included to describe a lack of problems in
the dimensions of health described by that measure [3].
In most of the valuation studies for the widely-used EQ-5D
instrument [4], including the UK EQ-5D value set study [5], values
were sought relative to the best health state in the descriptive
system using TTO (denoted by the descriptor 11111; where 1on behalf of International Society for Pharmacoeconomics and
conﬂicts of interest with regard to the content of this article.
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Recently, however, EQ-5D valuation studies have used a comparator
of “full health,” including those seeking to value the new ﬁve-level
version of the instrument, the EQ-5D-5L [6,7]. The EQ-5D-5L was
developed to address perceived concerns about the EQ-5D’s lack of
sensitivity to small changes in health (in particular, its ability to
capture mild health problems adequately) [8]. It comprises the same
core ﬁve dimensions (mobility; self-care; usual activities; pain/
discomfort; anxiety/depression) as the EQ-5D but increases the
available response options (“levels”) from three to ﬁve.
It is unclear how the speciﬁcation of the comparator health state
affects the valuations elicited. For example, recently conducted
valuation studies have reported lower than expected mean values
for very mild health states. In the EQ-5D-5L value set for England
study [9], the mean value elicited for the health state comprising
slight problems in walking about and no problems with the other four
dimensions (21111) was similar to the mean value elicited for the
corresponding EQ-5D (-3L) health state (some problems in walking
about and no problems with the other four dimensions; a more
severe state, but also denoted as 21111) [5]. Similar results were
observed for the other very mild health states, both in the England
study [9] and in parallel studies conducted elsewhere [6,7]. This is
surprising as these EQ-5D-5L health states are by design milder than
the corresponding EQ-5D-3L health states—level 2 denotes “slight”
problems in EQ-5D-5L compared with “some” problems in EQ-5D-3L.
This ﬁnding could represent changes in population preferences
since the early EQ-5D valuation studies were conducted but could
also be explained by several methodological developments such as
the use of computer-assisted surveys and changes to the operation-
alization of the valuation tasks. Some of the research supporting
these developments has been reported [10], but the change in
comparator health state from 11111 to full health has never, to the
best of our knowledge, been investigated. It is not clear whether the
two descriptors can be considered equivalent, empirically. We are
also unaware of any research investigating the value of 11111, and
how to interpret the gap between 11111 and full health, if any (one
study has reported an observed mean value of less than 1 for 11111
[11], but it is not clear how this value was obtained).
The primary objective of this study was to assess differences
in TTO health state valuations (particularly the valuation of very
mild health states) by using two different comparator health
states: full health and EQ-5D-5L health state 11111. Our null
hypothesis was that the valuations would not depend on the
choice of comparator health state. We were interested primarily
in the impact of the comparator health state on the average
values observed. Further, given that a possible study outcome
could be recommendation of the use of an alternative compara-
tor, we were also interested in the impact that such a change
might have on the face validity of the data and the overall value
elicitation process (commonly assessed by examining the extent
of inconsistencies in the responses and respondents’ reported
difﬁculties in understanding and completing the tasks).
Further objectives were to elicit the value of 11111 itself and to
examine people’s interpretations of the term “full health” and
alternative labels for the comparator health state.Methods
Administration of Survey
Stated preference data were collected from a sample of members
of the UK general public by using a valuation questionnaire based
closely on the protocol for valuing EQ-5D-5L [10]. The EuroQol
Group Valuation Technology (EQ-VT), a digital aid developed
speciﬁcally for EQ-5D-5L valuation studies, was used to administer
the valuation tasks and to capture the response data. The EQ-VTwas used as the basis for computer-assisted personal interviews,
undertaken by a team of three experienced interviewers working
for the Shefﬁeld Hallam University. The interviewers completed
training on the speciﬁcs of the methodology and procedures for
this study and were asked to follow step-by-step instructions and
a script in order to minimize interviewer bias. All interviews were
carried out in a one-to-one setting in the homes of respondents.
The sample comprised adult members of the general public in
South Yorkshire, United Kingdom. Ten areas were selected by
identifying every 18th or 19th area from an alphabetic list of 185
towns in the region. A central point in each area was then
selected, with the relevant postcode entered into the AFD Names
and Numbers software [12] to generate a database of residential
properties around this point. Letters of invitation to participate in
the study were sent to the selected addresses.
A “minimum quota” approach was used to ensure that the
sample was broadly representative of the general population in
terms of age and gender. The survey was given ethics approval by
the Ethics Committee of the University of Shefﬁeld’s School of
Health and Related Research.
Survey Instrument
Each respondent completed the following tasks (in order): self-
reported health using EQ-5D-5L and the EuroQol visual analogue
scale (EQ-VAS); sociodemographic questions; introduction to the
TTO exercise (including four warm-up tasks); 10 or 11 TTO
valuation tasks (depending on the study arm); structured feed-
back questions regarding the TTO tasks; 13 discrete choice
experiment tasks (not reported in this paper); structured feedback
questions regarding the discrete choice experiment tasks; and an
opportunity to leave further feedback using an open-ended text
box. Immediately after completing these tasks using EQ-VT,
respondents were asked to complete a short pen-and-paper
follow-up questionnaire (see below).
TTO Tasks
In the TTO tasks, a “composite” approach was used. This
involved beginning with “conventional” TTO for all health states,
and shifting to “lead-time” TTO [13] if the respondent indicated
that he or she considered the health state to be worse than dead.
Details of the composite TTO approach, as well as the results of
an empirical study supporting its use in the valuation of EQ-5D-
5L health states, are described by Janssen et al. [14].
The two hypothetical lives were labeled as Life A (time in the
comparator health state—either full health or 11111) and Life B
(time in the EQ-5D-5L health state under evaluation). At the
respondent’s point of indifference, the value for the health state
can be calculated (in the simplest case, with zero temporal
discounting) as follows:
U¼t=10 for conventional TTO ðbetterthandead health statesÞ
or U¼ðt10Þ=10 for leadtime TTO ðworsethandead health statesÞ
where U is the value (utility) and t is the number of years in Life A
at the respondent’s point of indifference. For more information,
see Oppe et al. [10].
Follow-up Questionnaire
The follow-up questionnaire comprised the following tasks: 1)
paired comparison task in which respondents were asked to
indicate whether they considered 11111 and full health to be “the
same as each other” and, if not, to explain what makes them
different from each other; 2) EQ-VAS rating of four health states,
including 11111 and full health; 3) ranking task in which
respondents were asked to rank six health state descriptions
(full health, perfect health, no health problems, best imaginable
health, 11111, healthy) in order of how much they would want to
V A L U E I N H E A L T H 1 9 ( 2 0 1 6 ) 5 3 – 5 9 55live in them; 4) open-ended question inviting respondents to
indicate any aspects of health and quality of life that they
consider to be important but are not captured by the ﬁve EQ-5D
dimensions. These follow-up tasks were developed by the study
team to elicit additional information about the comparability
between 11111 and full health and to inform the ongoing
research agenda around the measurement of quality of life
beyond the existing EQ-5D descriptive system.
Study Design
Respondents were randomly allocated to one of two study arms.
In the control arm, Life A was described in terms of time in “fullFig. 1 – Screenshots depicting TTO task in the control arm (upper) ahealth.” In the test arm, Life A was described in terms of time in
11111 (Fig. 1).
The EQ-5D-5L health states were hand-picked by the study
team so as to cover a variety of mild, moderate, and severe health
problems, with three very mild health states (21111, 11121, 11112)
included because of their particular relevance to the study
objectives. These health states can each be described as having
a level “sum score” (a proxy for severity; calculated by summing
the ﬁve dimension levels (i.e., 2 þ 1 þ 1 þ 1 þ 1 ¼ 6) of six. The
majority of health states included were taken from the exper-
imental design used to select health states for the EQ-5D-5L
valuation studies. The remaining were commonly occurring
health states that were relatively well represented in thend test arm (lower). (Color version of ﬁgure is available online.)
V A L U E I N H E A L T H 1 9 ( 2 0 1 6 ) 5 3 – 5 956self-reported health data in another largescale public preference
survey [15].
Respondents in the test arm each evaluated 10 health states
using TTO. Respondents in the control arm evaluated the same
10 health states and additionally valued health state 11111. The
order in which the health states were presented was randomized
with the exception of 11111, which was always presented last.
This is because of concerns that if some respondents consider
being asked to value 11111 a trivial or frivolous task, they might
pay less attention to the remaining valuation tasks.
The EQ-5D-5L dimensions were presented in three different
orderings to test for order effects. Each respondent was randomly
allocated to one of the three orderings and saw the same ordering
through all of the valuation tasks. The results of this part of the
study are reported elsewhere [16].Methods of Analysis
Descriptive statistics (mean, median, standard deviation) of the
health state values were compared across arms and against their
sum scores. The distributions of values were also compared
across arms.
The study design included a number of pairs of health states
whereby one state can be considered to logically “dominate” the
other (e.g., 21232 dominates 32442 because it is better on the ﬁrst
four dimensions and no worse on the ﬁfth). A respondent can be
described as having a logical inconsistency if, for any given pair
of dominant-dominated health states, they give a higher value to
the dominated state [17]. The propensity to give inconsistent
valuations was compared across arms.
Interviewer effects were assessed by comparing the distribu-
tions of values given by respondents interviewed by each of the
three interviewers. We also estimated a linear regression model
of the form:
y¼Xβþε
where y is the health state value, X represents the explanatory
variables, and ε represents the error term capturing other factors.
Study arm, interviewer (one dummy variable for each inter-
viewer), and sequence (a proxy for interviewer learning effects:
a dummy variable taking a value of 1 if the interview was one ofTable 1 – Descriptive statistics for the health state value
State Sum
score
Control (full health arm)
n Mean Median SD n
11111 5 227 0.999 1.00 0.009 0
21111 6 227 0.957 1.00 0.117 216
11121 6 227 0.970 1.00 0.079 216
11112 6 227 0.961 1.00 0.091 216
11223 9 227 0.823 0.95 0.291 216
21232 10 227 0.830 0.95 0.264 216
43331 14 227 0.591 0.75 0.485 216
32442 15 227 0.437 0.50 0.507 216
55233 18 227 0.292 0.50 0.603 216
34155 18 227 0.184 0.35 0.593 216
55555 25 227 -0.182 0.00 0.554 216
One-way test: two-sample Student’s t test examining whether the mean
one-way test is based on the observation that the test arm generated low
Two-way test: two-sample Student’s t test examining whether the mean
* Statistically signiﬁcant at the 5% level.the ﬁrst 20 undertaken by the interviewer, and 0 otherwise) were
included as the explanatory variables.
Descriptive statistics of respondents’ self-reported health
were examined, with particular focus on respondents who self-
reported as being in health state 11111. Responses to the feed-
back questions were analyzed by comparing the proportions of
respondents who agreed or strongly agreed with each feedback
statement across arms.
Comparisons across arms were assessed using chi-squared
and two-sample Student’s t tests. Analyses were undertaken
using Microsoft Excel and STATA 11.2 software.Results
The interviews were conducted between May and October 2014.
In accordance with the ethical approval for this study, respond-
ents who did not complete the interview in full were excluded
from the analysis (n ¼ 6). We also excluded the data for 13
respondents who gave the same value in all of the TTO tasks.
This is consistent with the exclusion criteria used in previous
valuation studies [18]. Excluding these individuals resulted in a
sample of 443 respondents, of whom 227 (51.2%) were allocated to
the control arm and 216 (48.8%) to the test arm.
Older individuals (35.9% of the sample are aged 60 years and
over) and males (58.2%) were over-represented in comparison
with the general population [19]. The sample was also relatively
well-educated, with 44.5% of respondents educated to university
degree level or an equivalent level. We observed no statistically
signiﬁcant associations between the study arms and these or
other background characteristics (chi-squared test; in all cases P
4 0.05).
The difference in mean completion times across the arms was
not statistically signiﬁcant (Student’s t test; P ¼ 0.61).
Valuation Data
Table 1 summarizes the descriptive statistics for the health states
valued. The mean values are higher in the control arm for all
health states except 21111, although for most states the differ-
ences are small and nonsigniﬁcant.
Figure 2 groups the health states by their sum scores and
shows that the mean TTO values decrease as the sum scored, by arm.
Test (11111 arm)
Mean Median SD One-way t
test P value
Two-way t
test P value
N/A N/A
0.962 1.00 0.119 0.672 0.657
0.962 1.00 0.116 0.218 0.437
0.936 1.00 0.195 0.045* 0.090
0.814 0.95 0.335 0.390 0.780
0.789 0.90 0.306 0.068 0.137
0.571 0.70 0.482 0.331 0.662
0.325 0.45 0.598 0.017* 0.033*
0.264 0.40 0.621 0.311 0.623
0.116 0.30 0.647 0.123 0.246
-0.194 0.00 0.576 0.410 0.819
of the test arm is less than the mean of the control arm (direction of
er mean values than the control arm for most of the health states).
of the test arm is different from the mean of the control arm.
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Fig. 2 – Mean TTO value, by sum score. (Color version of
ﬁgure is available online.)
V A L U E I N H E A L T H 1 9 ( 2 0 1 6 ) 5 3 – 5 9 57increases, an indicator of the face validity of the data. Higher
mean values were observed in the control arm for the very mild
health states (i.e., those with a sum score of six), but the differ-
ence was not statistically signiﬁcant at the 5% level (Student’s t
test; P ¼ 0.10).
Figure 3 shows, for each arm, the overall distribution of TTO
values for all health states combined except for 11111, which was
valued only by respondents in the control arm. The relatively
large number of observations at 0.95 and 1 reﬂect the inclusion of
the three very mild health states in the design of this study (in
the experimental design used to select health states for the EQ-
5D-5L valuation studies, most blocks contain only one health
state with a sum score of six). We observed some clustering at
other “round-number” values, speciﬁcally at –1, 0, 0.5, and 1, but
overall the distributions are smoother than those observed in
previous EQ-5D-5L studies [6,7,9].
Overall, 112 respondents (25.3%) gave valuations that included
at least one inconsistency (as deﬁned above). The mean number
of inconsistencies per respondent was 0.4. We did not observe a
statistically signiﬁcant association between the study arms and
the propensity to give inconsistent valuations (chi-squared test; P
¼ 0.16).
Of the 227 respondents who valued health state 11111, 223
(98.2%) gave it a value of 1. The lowest value given to 11111 was 0.9.Interviewer Effects
A team of three interviewers was used (INV1, 115 interviews;
INV2, 169 interviews; INV3, 159 interviews). The random alloca-
tion of respondents to the study arms resulted in an uneven
distribution at the interviewer level, with 57.1% of respondents
interviewed by INV3 but only 45.8% of respondents interviewed0%
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Fig. 3 – TTO valuation distribution across all health states (excepby INV1 being allocated to the control arm. Figure 4 highlights the
differences in the data collected by the three interviewers. For
example, respondents interviewed by INV1 were more (or less)
likely to give health states a value of –1 (0).
Regression analysis suggested that interviewer effects were
present. The coefﬁcients for interviewer (INV1: Po 0.01; INV3; P ¼
0.02) and sequence (P o 0.01) were statistically signiﬁcant; the
coefﬁcient for the study arms was not (P ¼ 0.18).
Self-Reported Health
When asked about their own level of health on the day of the
interview, 224 respondents (50.6%) self-reported as being in
health state 11111. Of these 224 respondents, 187 (83.5%) self-
reported an EQ-VAS score of less than 100, indicating that despite
having no problems in the ﬁve dimensions covered by EQ-5D,
they considered their level of health to fall short of the EQ-VAS
upper anchor of “best imaginable health.” The mean (median)
EQ-VAS score for respondents self-reporting as being in 11111
was 89.1 (90).
Feedback
In the structured feedback questions, all respondents were asked
to indicate their level of agreement (via ﬁve-point Likert items
ranging from “strongly agree” to “strongly disagree”) with the
following three statements: 1) “It was easy to understand the
questions I was asked”; 2) “I found it easy to tell the difference
between the lives I was asked to think about”; and 3) “I found it
difﬁcult to decide on the exact points where Life A and Life B were
about the same.” The vast majority of respondents agreed or
strongly agreed with statements 1 and 2 (91.4% and 90.3%,
respectively). Opinion regarding statement 3 was more divided,
with 50.7% of the respondents agreeing or strongly agreeing with
it. We do not observe a statistically signiﬁcant association
between the study arms and the propensity to agree or strongly
agree with any of the three statements.
Follow-up Questions
Responses to the follow-up questions are available for 436
respondents. These data are unavailable for the remaining seven
respondents because of a recording error. The missing data are
not expected to differ systematically from those of the rest of the
sample.
When asked to compare 11111 and full health, 305 respond-
ents (70.1%) stated that they considered the two descriptions to
be the same as each other. The respondents who did not consider
them to be the same offered explanations such as:-0
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Fig. 4 – TTO valuation distribution across all health states (except 1111), by interviewer. (Color version of ﬁgure is available online.)
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and social well-being. Someone can have everything on the
left-hand side of the list and still not be in full health because
of loneliness.” “[11111] seems to stress physical capabilities. Full health must
include emotional and mental conditions.” “Being in full health means nothing is wrong, whereas over-
weight unhealthy people may not have any problems
walking.”
A total of 374 respondents (86.0%) gave full health an EQ-VAS
score of 100 (mean score: 98.6). In contrast, 253 respondents
(58.2%) gave 11111 an EQ-VAS score of 100 (mean score: 95.1).
Of the six health state descriptions included in the ranking
task, “perfect health” was most often ranked as the state that
respondents most wanted to live in (ranked best or joint-best by
60.5% of respondents), followed by (in order) “full health,” “best
imaginable health,” “no health problems,” 11111, and “healthy.”
Full health and 11111 were ranked best/joint-best by 42.7% and
20.9% of respondents, respectively.
One hundred and seventy-seven respondents (40.6%) stated
that there were aspects of health that they considered important
but were not covered by the ﬁve EQ-5D dimensions. These
included vision, hearing, energy, and sociability. A similar num-
ber of respondents (202; 46.3%) stated that there were important
aspects of quality of life that were not covered by EQ-5D.Discussion
The results of this study suggest that the EQ-5D-5L health state
values elicited by using the composite TTO approach are not
greatly affected by whether full health or 11111 is used as the
comparator health state. We examined a number of standard
measures of the quality and face validity of the TTO data. The
propensity for respondents to give inconsistent valuations was
not found to be associated with the choice of comparator health
state. In both study arms, higher average values were observed
for health states that can be considered relatively milder, and
lower average values were observed for more severe health
states. This suggests that the data have acceptable face validity,
and we did not observe differences across the arms in this
respect.
Overall, the average values were higher in the control arm.
This was not the case, however, for all of the health states, and
for the very mild health states, the observed difference was not
statistically signiﬁcant. Further, the difference appears to bedriven by interviewer effects (respondents interviewed by INV1
tended to give lower values overall and were allocated dispro-
portionately to the test arm) rather than by inherent differences
between the arms. Interviewer-led administration of complex
stated preference surveys is usually preferred because of the
need for interviewers to explain instructions and to guide the
respondents [20,21]. This can result, however, in interviewer bias
because different individuals have different interviewing styles.
The results presented here demonstrate that the differences
in values between the recent EQ-5D-5L valuation studies and the
earlier EQ-5D value sets are not explained by the change in the
description of the comparator health state. It should also be
noted, however, that the low mean values for the very mild
health states in the EQ-5D-5L value set for England study [9] were
not observed in either arm of the current study. This suggests
that other factors (such as the use of different groups of
interviewers or other changes to the valuation protocol) were
more inﬂuential than the choice of comparator state in determin-
ing the health state values.
Almost all of the respondents who valued 11111 via TTO gave
it a value of 1. Yet many respondents indicated, through their
responses to the follow-up questions, that they did not consider
full health and 11111 to be the same, with full health rated and
ranked higher than 11111 overall. In the EQ-5D-5L valuation
protocol, it is not possible to make trades of less than 6 months,
which means that the highest value (other than 1) that can be
given to a health state is 0.95. It is conceivable that many
respondents consider living in full health for 10 years to be better
than living in 11111 for 10 years (in which case 11111 should have
a value of less than 1) but would not be willing to trade as much
as 6 months of life in order to live in full health rather than 11111.
Nevertheless, this study provides no empirical evidence to
suggest that assigning a value of 1 to health state 11111 is
problematic.
The ﬁnding that many respondents self-reported as being in
11111 while also self-reporting an EQ-VAS score of less than 100
is not unexpected. It is consistent with the results of the ranking
task, in which the EQ-VAS upper anchor—“best imaginable
health”—was ranked higher than 11111 overall. A detailed anal-
ysis of the responses to the follow-up questions is reported
elsewhere [22]. We would encourage qualitative research that
seeks to further develop our understanding of what the different
candidate upper anchor represent and how the various descrip-
tors are interpreted by respondents. Although the evidence
suggests that the TTO values elicited are largely unaffected by
whether full health or 11111 is used as the comparator health
state, there may be other reasons for preferring one comparator
V A L U E I N H E A L T H 1 9 ( 2 0 1 6 ) 5 3 – 5 9 59or the other. On the one hand, the term “full health” does not
translate exactly into some languages such as Arabic [23], which
makes comparisons across countries challenging. On the other
hand, the literature makes it clear that QALYs are anchored at
full health rather than at an instrument-speciﬁc best health state
[24]. Indeed, TTO is used to value not only EQ-5D-5L health states
but also health states deﬁned by other health-related quality of
life instruments [25], so a consistent upper anchor is needed in
order for the values elicited to be fully comparable.
Some limitations of the study design should be mentioned.
The study arms were less well matched than desirable. Following
the computerized randomization procedure, respondents inter-
viewed by INV3 were more likely to be allocated to the control
arm compared with those interviewed by INV1. Future studies
should consider making provisions to ensure that each inter-
viewer is allocated an equal number of respondents in each arm.
Using a larger interviewer team might also have lessened the
impact of any one interviewer on the overall study results,
although this potential beneﬁt should be considered alongside
the fact that larger interviewer teams are generally more difﬁcult
to train and monitor than smaller teams.
The follow-up questions offer useful insights and supporting
evidence. It should be noted, however, that these questions had not
been piloted or used in previous research, so we cannot be certain
that they were well understood by respondents (though the inter-
viewers did not report any perceived difﬁculties in understanding).Conclusion
Notwithstanding the limitations described above, we have dem-
onstrated in this paper that the choice of comparator health state
does not greatly affect EQ-5D-5L values elicited by using the
composite TTO approach.Acknowledgments
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